Contact Pfizer Media Relations

This information is intended for media professionals.

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

If you are not a journalist, please visit the Contact Page and consult the appropriate Pfizer contact.

Phone: (212) 573-1226

You can also visit our Pfizer Worldwide Web Sites.

Contact	Responsibility	Key Focus Areas / Issues (Not all-inclusive)
Ray Kerins W: 212-733-9203 C: 917-324-0080 Raymond.Kerins@pfizer.com	Vice President, Corporate Communications
Chris Loder W: 212-733-7897 C: 347-453-8199 Christopher.Loder@pfizer.com	Head of Media Relations — United States, Animal Health	Litigation; Counterfeiting
Kristen Neese W: 212-733-8926 C: 646-299-2526 Kristen.E.Neese@pfizer.com	Science, Medical & Regulatory Media Relations
Joan Campion W: 212-733-2798 C: 201-761-9384 Joan.Campion@pfizer.com	Corporate / Financial Media Relations	Finance; Earnings / SEC Filings; Corporate Governance; Business Development
MacKay Jimeson W: 212-733-2324 C: 347-439-5647 MacKay.Jimeson@pfizer.com	Primary Care	Lyrica, Celebrex, Spiriva, Toviaz, Dimebon, Apixaban, Tanezumab, Lipitor, Viagra, Chantix, Premarin Family and Pristiq
Victoria Davis W: 484-865-5194 C: 347-558-3455 Victoria.Davis@pfizer.com	Specialty Care & Vaccines	Enbrel, Prevenar
Gwen Fisher W: 484-865-5160 C: 215-407-1548 Gwen.Fisher@pfizer.com	Business Development, Strategy & Innovation
Jennifer Kokell W: 212-733-2596 C: 917-741-4254 Jennifer.Kokell@pfizer.com	Nutrition, Corporate Responsibility Media Relations — Latin America
Andrew Topen W: 44-1737-332236 C: 44-7967-757688 Andrew.Topen@pfizer.com EUPress@pfizer.com	Head of Media Relations — Europe, Africa & Middle East & Asia Pacific
Andrew Widger W: 44-1737-330909 C: 44-797-0149098 Andrew.Widger@pfizer.com EUPress@pfizer.com	Africa, Middle East Media Relations
Adam Linka W: 48-22-3356356 C: 48-601-382783 Adam Linka EUPress@pfizer.com	Europe Media Relations
Dawn Carty W: 353-1-4694702 C: 353-87-9718312 dawn.carty@pfizer.com EUPress@pfizer.com	Europe Media Relations
Lauren Starr W: 212-733-3221 C: 646-761-0965	Research and Development
Trupti Deepak Wagh C: +65 918-732-47	Director Media Relations Asia Pacific
Jenifer Antonacci W: 484-865-5218 C: 610-427-0369 Jenifer.Antonacci@pfizer.com	Oncology; Consumer Products

Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

Text SizeAAA

Stock Symbol: PFE Stock Exchange: NYSE

Stock Quote at: Feb 8 2012 4:00PM

Last 21.01

Change -0.04

%Change	-0.19	Vol.	34,144,266
Day High	21.08	52 Wk. High	22.17
Day Low	20.85	52 Wk. Low	16.63
Open	21.00	Mkt. Cap(Bil)	161.50
Prev. Close	21.05

Cost Basis Calculator

Our Impact on people, science and the world.

View the Interactive 2010 Annual Report

Copyright © 2002–2012 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc. is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.